Class Action Lawsuit Filed Against Monolithic Power Systems: What Does It Mean for Investors and the World? On March 21, 2025, Bronstein, Gewirtz & Grossman, LLC, a prominent law firm, announced the filing of a class action lawsuit against Monolithic Power Systems, Inc. (Monolithic Power Systems or MPWR) and certain of its officers. The lawsuit…
Welcome Investors! Are you an investor who has suffered losses in Enphase Energy? Securities Litigation Partner James (Josh) Wilson of Faruqi & Faruqi, LLP is here to help. With years of experience in securities litigation, he is dedicated to assisting investors like you in exploring your legal options. Why Choose Faruqi & Faruqi, LLP? At…
The Reversal of Bullish Trump Trades: A Souring Economic Outlook Following Donald Trump’s surprise victory in the 2016 U.S. presidential election, there was a wave of euphoria across several asset classes. Investors were optimistic about the prospect of tax reforms, deregulation, and infrastructure spending under a Republican-controlled government. However, the initial excitement has turned sour…
Levi & Korsinsky Investigates CARGO Therapeutics, Inc. for Securities Violations February 11, 2025 – New York, NY Levi & Korsinsky notifies investors that it has commenced an investigation of CARGO Therapeutics, Inc. (“CARGO Therapeutics, Inc.”) (NASDAQ:CRGX) concerning possible violations of federal securities laws. On January 29, 2025, CARGO announced in a press release that it…
AT&T Inc. Quarter Earnings Report Analysis Overview AT&T Inc. (T) is set to report its fourth-quarter earnings on Monday. Wall Street analysts are expecting the company to report earnings per share (EPS) of 50 cents and revenues of $32.04 billion before the market opens. Previous Performance Looking at AT&T’s third-quarter earnings report, the company reported…
Attention Investors: Mullen Automotive Inc. Securities Class Action Lawsuit Investors who have suffered significant losses due to their investment in Mullen Automotive Inc. (NASDAQ: MULN) are encouraged to contact James (Josh) Wilson, partner at Faruqi & Faruqi, LLP’s Securities Department, directly to discuss their potential options for recovery. The securities class action lawsuit alleges that…
Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB ) Q4 2024 Earnings Conference Call: Key Highlights On March 4, 2025, Y-mAbs Therapeutics, Inc. held its earnings conference call for the fourth quarter and full year 2024. The call was led by Courtney Dugan, Head-IR, Michael Rossi, President & CEO, Doug Gentilcore, Senior VP & Head of DANYELZA Business…
Anavex Announces Breakthrough in Alzheimer’s Disease Research Introduction: A recent study has revealed promising results in the treatment of Alzheimer’s and Parkinson’s disease through the use of ANAVEX®2-73. The expression levels of pathological dysregulated neurodegenerative genes associated with both diseases showed significant restoration after receiving this therapeutic treatment. Study Findings: The study showed that ANAVEX®2-73…
